; ;
Run your own event Donations as a gift Volunteer At work Corporate Partnerships
Participating Hospitals In development Recruiting In follow-up Completed Endorsed Studies Publications
Aims & Objectives Our Board Advisory Committee Consumer Panel Membership Network International Partners Achievements Publications
Cancer_sites
donate
Name
Email
Sign up to keep informed

login

GASTRO-INTESTINAL CANCERS


Overview

Gastro-Intestinal cancer is a term for the group of cancers that affect the digestive system. This includes cancers of the oesophagus, gallbladder, liver, pancreas, stomach and bowel (the bowel includes the small intestine, large intestine or colon and rectum).

GI Cancer Statistics

GI cancers include cancers of the oesophagus, gallbladder, liver, pancreas, stomach and bowel (ie the digestive system).
  • Over 20,000 Australians are diagnosed with GI cancers each year
  • 26 Australians will die each day from a GI cancer
  • Only 5% of people contracting pancreatic cancer live more than 5 yrs
  • Gastro-Intestinal cancer do not discriminate between men & women
  • The 5 year survival rate of people with cancers of the stomach is (25%), colon (61%) and rectum (63%).

Clinical trials to find better treatments

Treatment for Gastro-Intestinal cancer will depend on the type of cancer, the stage or its development, and other health factors. Treatment commonly includes surgery, chemotherapy and radiation therapy.

The AGITG carries out clincal trials to find the most effective combination, doses and types of treatment to best suit patients. The aims of our trials are to improve treatment outcomes for patients and boost their quality of life.

As a result of using our clinical trials major advances in treating GI cancers and improving patient quality of life are possible.

GI Cancer incidence in Australians, 2005

cancer_statistics